Cytidine‐5′‐diphosphocholine (Citicoline): a pilot study in patients with non‐arteritic ischaemic optic neuropathy

No abstract is available for this paper.

• Publication year

  2008

• Venue

  European Journal of Neurology

• Publication date

  2008-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1468-1331.2008.02099.xPMID 18325025
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy and tolerability of 0.2% brimonidine tartrate for the treatment of acute non-arteritic anterior ischemic optic neuropathy (NAION): a 3-month, double-masked, randomised, placebo-controlled trial

  2006cited by this paper
• Giant Cell Arteritis and Polymyalgia Rheumatica

  2006cited by this paper
• Clinical ability of pattern electroretinograms and visual evoked potentials in detecting visual dysfunction in ocular hypertension and glaucoma.

  2006cited by this paper
• Dopamine regulates melanopsin mRNA expression in intrinsically photosensitive retinal ganglion cells

  2005cited by this paper
• Efficacy of levodopa and carbidopa on visual function in patients with non‐arteritic anterior ischaemic optic neuropathy

  2005cited by this paper
• Nonarteritic anterior ischemic optic neuropathy

  2005cited by this paper
• Non-arteritic anterior ischemic optic neuropathy

  2005cited by this paper
• Visual field abnormalities in nonarteritic anterior ischemic optic neuropathy: their pattern and prevalence at initial examination.

  2005cited by this paper
• Electrophysiological Assessment of Glaucomatous Visual Dysfunction During Treatment with Cytidine-5′-diphosphocholine (citicoline): A Study of 8 years of Follow-up

  2005cited by this paper
• Therapeutic value of citicoline in the treatment of glaucoma (computerized and automated perimetric investigation)

  2005cited by this paper
• Ischemic optic neuropathies

  2004cited by this paper
• Dopamine and retinal function

  2004cited by this paper
• Visual dysfunction, neurodegenerative diseases, and aging.

  2003cited by this paper
• Giant-Cell Arteritis and Polymyalgia Rheumatica

  2003cited by this paper
• Citicoline Treatment Increases Retinal Dopamine Content in Rabbits

  2002cited by this paper
• Anterior ischemic optic neuropathy in children: case reports and review of the literature.

  2002cited by this paper
• Pharmacodynamics of citicoline relevant to the treatment of glaucoma

  2002cited by this paper
• Treatment of ischemic optic neuropathy

  2002cited by this paper
• Correlation between optical coherence tomography, pattern electroretinogram, and visual evoked potentials in open-angle glaucoma patients.

  2001cited by this paper
• Ischemic optic neuropathies.

  2001cited by this paper
• Optic disc morphology after arteritic anterior ischemic optic neuropathy.

  2001cited by this paper
• The protective effect of citicoline on the progression of the perimetric defects in glaucomatous patients (perimetric study with a 10-year follow-up).

  2000cited by this paper
• Histopathologic studies of ischemic optic neuropathy.

  2000cited by this paper
• Visual loss after spine surgery: a survey.

  2000cited by this paper
• Correlation between morphological and functional retinal impairment in multiple sclerosis patients.

  1999cited by this paper
• Citicoline protects hippocampal neurons against apoptosis induced by brain beta-amyloid deposits plus cerebral hypoperfusion in rats.

  1999cited by this paper
• Neuroprotection in relation to retinal ischemia and relevance to glaucoma.

  1999cited by this paper
• Ganglion cell death in glaucoma: what do we really know?

  1999cited by this paper
• Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.

  1999cited by this paper
• Cytidine-5'-diphosphocholine (citicoline) improves retinal and cortical responses in patients with glaucoma.

  1999cited by this paper
• Cytidine-5'-diphosphocholine improves visual acuity, contrast sensitivity and visually-evoked potentials of amblyopic subjects.

  1998cited by this paper
• Effect of levodopa and carbidopa on recovery of visual function in patients with nonarteritic anterior ischemic optic neuropathy of longer than six months' duration.

  1996cited by this paper
• Therapeutic Effects of CDP‐Choline in Alzheimer's Disease‐Cognition, Brain Mapping, Cerebrovascular Hemodynamics, and Immune Factors a

  1996cited by this paper
• Pain in Anterior Ischemic Optic Neuropathy

  1995cited by this paper
• Visual alterations in de novo Parkinson's disease

  1995cited by this paper
• CDP-choline: pharmacological and clinical review.

  1995influential reference
• Are there dopaminergic ganglion cells in the mammalian retina?

  1995cited by this paper
• Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. The Ischemic Optic Neuropathy Decompression Trial Research Group.

  1995cited by this paper
• Painful ophthalmoplegia associated with lymphoid hyperplasia of the nasopharynx

  1995cited by this paper
• Postoperative Ischemic Optic Neuropathy

  1995cited by this paper
• Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicoline.

  1995influential reference
• Dopaminergic modulation of visual sensitivity in man

  1993cited by this paper
• Effect of decreased retinal illumination on simultaneously recorded pattern electroretinograms and visual-evoked potentials.

  1991cited by this paper
• Effects of CDP-choline on the recovery of patients with head injury.

  1991cited by this paper
• Chapter 10 Functional roles of dopamine in the vertebrate retina

  1991cited by this paper
• Clinical trial on the use of cytidine diphosphate choline in Parkinson's disease.

  1988cited by this paper
• Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study.

  1988cited by this paper
• Effects of CDP-choline on neurologic deficits and cerebral glucose metabolism in a rat model of cerebral ischemia.

  1988cited by this paper
• Dopaminergic innervation of the primary visual cortex in the rat, and some correlations with human cortex.

  1987cited by this paper
• Simultaneous recording of pattern electroretinography and visual evoked potentials in multiple sclerosis. A method to separate demyelination from axonal damage to the optic nerve.

  1986cited by this paper
• Pattern ERGs and visual evoked potentials in maculopathies and optic nerve diseases.

  1985cited by this paper
• Clinical profile and long-term implications of anterior ischemic optic neuropathy.

  1983cited by this paper
• Effect of CDP-choline on the biosynthesis of nucleic acids and proteins in brain regions during hypoxia

  1981cited by this paper
• Electroretinographic responses to alternating gratings before and after section of the optic nerve.

  1981cited by this paper
• Action of cytidine diphosphocholine on functional and hemodynamic effects of cerebral ischemia in cats.

  1978cited by this paper
• The function of cytidine coenzymes in the biosynthesis of phospholipides.

  1956cited by this paper

• Neuroprotection beyond intraocular pressure: game changer or quiet addiction

  2025cites this paper
• The effect of citicoline oral solution on quality of life in patients with glaucoma: the results of an international, multicenter, randomized, placebo-controlled cross-over trial

  2023cites this paper
• Citicoline: pharmacological and clinical review, 2022 update

  2022cites this paper
• Neuroprotection in glaucoma

  2022influential citation
• Citicoline and Vitamin B12 Eye Drops in Type 1 Diabetes: Results of a 36-Month Pilot Study Evaluating Macular Electrophysiological Changes

  2021cites this paper
• Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control

  2021influential citation
• Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review

  2021influential citation
• Bedeutung von Citicolin bei der Glaukomerkrankung

  2021cites this paper
• Citicoline (CDP-Choline)

  2020cites this paper
• Can Treatment With Citicoline Eyedrops Reduce Progression in Glaucoma? The Results of a Randomized Placebo-controlled Clinical Trial

  2020cites this paper
• Effect of neuroprotective citicoline eye drops on macular microcirculation

  2020cites this paper
• Cytidine 5′-Diphosphocholine (Citicoline): Evidence for a Neuroprotective Role in Glaucoma

  2020cites this paper
• Treatment with Citicoline Eye Drops Glaucomatous Optic Neuropathy

  2020cites this paper
• Visual Evoked Potentials in Joubert Syndrome: A Suggested Useful Method for Evaluating Future Approaches Targeted to Improve Visual Pathways’ Function

  2020cites this paper
• Human vitreous concentrations of citicoline following topical application of citicoline 2% ophthalmic solution

  2019cites this paper
• Citicoline and Eye Health

  2019cites this paper
• The Effect of Citicoline on Electroretinography Abnormalities in Patients with Non-proliferative Diabetic Retinopathy

  2019cites this paper
• Cholinergic nervous system and glaucoma: From basic science to clinical applications.

  2019cites this paper
• Neuroprotective Effect of Citicoline Eye Drops on Corneal Sensitivity After LASIK.

  2019cites this paper
• The Effect of Citicoline Supplementation on Motor Speed and Attention in Adolescent Males

  2019cites this paper
• Neuroenhancement and neuroprotection by oral solution citicoline in non-arteritic ischemic optic neuropathy as a model of neurodegeneration: A randomized pilot study

  2019influential citation
• Citicoline and Retinal Ganglion Cells: Effects on Morphology and Function

  2017influential citation
• Chapter 9 Neuroprotection in Glaucoma

  2017cites this paper
• Citicoline – a neuroprotector with proven effects on glaucomatous disease

  2017cites this paper
• Molecular structure and differential function of choline kinases CHKα and CHKβ in musculoskeletal system and cancer.

  2017cites this paper
• The Role of Nucleotides in Glial Cells during Peripheral Nerve Trauma and Compressive Disorders

  2017influential citation
• Neuroprotection in Glaucoma: Old and New Promising Treatments

  2017cites this paper
• Levodopa as a possible treatment of visual loss in nonarteritic anterior ischemic optic neuropathy

  2016cites this paper
• Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma

  2015cites this paper
• Cytidine 5′-Diphosphocholine (Citicoline) in Glaucoma: Rationale of Its Use, Current Evidence and Future Perspectives

  2015cites this paper
• Metabolomics in non-arteritic anterior ischemic optic neuropathy patients by liquid chromatography–quadrupole time-of-flight mass spectrometry

  2015cites this paper
• Scientific opinion on the substantiation of a health claim related to cytidine 5′-diphosphocholine and maintenance of normal vision pursuant to Article 13(5) of Regulation (EC) No 1924/2006.

  2014cites this paper
• An overview of clinical and therapeutic implications of citicoline

  2014cites this paper
• EFSA NDA Panel (EFSA on Dietetic Products, Nutrition and Allergies), 2014. Scientific Opinion on the substantiation of a health claim related to cytidine 5 diphosphocholine and maintenance of normal vision pursuant to Article 13(5) of Regulation (EC) No 1924/2006

  2014influential citation
• Effects of Coenzyme Q10 in Conjunction With Vitamin E on Retinal-evoked and Cortical-evoked Responses in Patients With Open-angle Glaucoma

  2014cites this paper
• Citicoline Oral Solution in Glaucoma: Is There a Role in Slowing Disease Progression?

  2013cites this paper
• Neuroprotection in Glaucoma

  2013cites this paper
• Citicoline: pharmacological and clinical review, 2010 update.

  2011cites this paper
• Citicolina: revisión farmacológica y clínica, actualización 2010

  2011cites this paper
• Chapter 41 – Ischemic optic neuropathy

  2010cites this paper
• Citicoline: A Novel Therapeutic Agent with Neuroprotective, Neuromodulatory, and Neuroregenerative Properties

  2010cites this paper
• Efficacy and safety of oral citicoline in acute ischemic stroke: drug surveillance study in 4,191 cases.

  2009cites this paper
• Neuroprotective effect of recombinant human erythropoietin on optic nerve injury in rats.

  2009cites this paper
• Non-arteritic anterior ischaemic optic neuropathy: a review and update.

  2009cites this paper
• Citicoline: update on a promising and widely available agent for neuroprotection and neurorepair.

  2008cites this paper